|aarongarc||Дата: Вторник, 06.10.2015, 12:38 | Сообщение # 1|
Albendazole should be discontinued in all patients if clinically significant decreases in blood cell counts occur.
In clinical trials, albendazole has been associated with mild to moderate elevations of hepatic enzymes. These elevations have generally returned to normal upon discontinuation of albendazole therapy.
Patients being treated for neurocysticercosis should receive anticonvulsant and steroid therapy as required. http://nickolasall26.tumblr.com/post/130542620551/generic-name-albendazole-verbal - Albendazole Preis (oral or IV) should be considered to prevent cerebral hypertensive episodes during the first week of treatment.
Preexisting neurocysticercosis may be found in patients treated with albendazole for other conditions. If patients experience neurological symptoms soon after treatment due to an inflammatory reaction caused by parasitic death within the brain, appropriate steroid and anticonvulsant therapy should be started at once.
Cysticercosis may involve the retina in rare cases. Before starting neurocysticercosis therapy, the patient should be examined for retinal lesions. If such lesions are present, the need for anticysticeral therapy should be weighed against the possibility of retinal damage caused by albendazole-induced changes to the retinal lesion.
If pregnancy occurs while taking albendazole, therapy should be discontinued at once and the patient should be apprised of the potential risk to the fetus.
Data not available
Albendazole should be administered with food.
In patients who have difficulty swallowing the tablets whole, the tablets should be crushed or chewed and swallowed with a little water.